| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 50 Number 2
Volume 50 Number 1
Volume 49 Number 6
Volume 49 Number 5
Volume 49S Number 1
Volume 49 Number 4
Earlier issues
Volume 49 Number 3


Research articles

ScienceAsia 50 (2024):ID 2024061 1-6 |doi: 10.2306/scienceasia1513-1874.2024.061


Cyclic intermittent hypoxia induces apoptosis through upregulation of LncRNA GAS5 expression in cardiomyocyte


Jiayuan Pua,b, Yan Zhaob, Xue Baia, Tao Fenga, Wenqiang Lua, Lihui Dinga, Qin Yua

 
ABSTRACT:     Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) is a common disorder that disrupts breathing during sleep, with known links to several heart-related conditions. Investigating the underlying mechanisms can guide the creation of new treatments. We focused on the role of specific genetic regulators, known as long non-coding RNAs (lncRNAs), which recent evidence suggests may play a part in heart disease resulting from OSAHS. Our study explored how a simulated OSAHS condition, Cyclic Intermittent Hypoxia (CIH), affects heart cells. We found that CIH increases levels of the lncRNA GAS5 and an enzyme called TRIM11, while reducing the levels of Bcl-2, a molecule that prevents cell death, thus leading to increased heart cell apoptosis. We also demonstrated that a microRNA, miR-205-5p, is a key player in this process, as it can modify the effect of GAS5 on TRIM11. Introducing miR-205-5p mimics lessened the impact of GAS5 on TRIM11. Our findings reveal a novel lncRNA GAS5/miR-205-5p/TRIM11 pathway by which OSAHS may cause heart damage. This research offers fresh insights into the molecular dynamics of heart injury induced by OSAHS and may inform future therapeutic strategies.

Download PDF

0 Downloads 32 Views


a Department of Pulmonology and Critical Care Medicine, The First Hospital of Lanzhou University, Gansu 730000 China
b The First School of Clinical Medicine, Lanzhou University, Gansu 730000 China

* Corresponding author, E-mail: yuqin@lzu.edu.cn

Received 1 Aug 2023, Accepted 19 Apr 2024